AML | 51成人动漫

Treatment Updates for Relapsed/Refractory AML

In round one of their discussion on Acute Myeloid Leukemia, Catherine Lai, MD, and Alice Mims, MD, discuss treatment updates from EHA2024 for recurrent/progressive AML patients.

December 21, 2024 鈥� 4 mins 32 secs

Up Next

Treatment Updates for Relapsed/Refractory AML

鈻� 4 mins

2024 Update on Menin Inhibitors in AML

鈻� 3 mins

I-Data study: Newly Diagnosed IDH Mutated AML Patients

鈻� 3 mins

Comparing IDH1 Inhibitors: Ivosidenib vs. Olutasidenib in Relapsed/Refractory Settings

鈻� 3 mins

Exploring IRAK4 and FLT3 Inhibitors in AML: The Take AIM Study

鈻� 2 mins

New Targets in AML: CLIC-2, Polo-like Kinase Inhibitors, and TP53 Mutation Strategies

鈻� 3 mins

Advances in AML and Bone Marrow Transplants

鈻� 4 mins

Enhancing Post-Transplant Co-Management

鈻� 2 mins

Testing Options in AML

鈻� 4 mins

Waiting for AML Test Results

鈻� 4 mins